Contract 75N94025P00476
Us Specialty Formulations Llc · Department Of Health And Human Services · August 6, 2025
Us Specialty Formulations Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 6, 2025 for $72,000 of work in medicinal and botanical manufacturing. Performance is in Allentown, PA. It was awarded under a small business set-aside. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N94025P00476
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Chemicals
- Place of performance
- Allentown, PA
- First action
- August 6, 2025
Description
NIAAA: CHEMICAL MANUFACTURING CLINICAL ETHANOL - SEVERABLE
Modification timeline
-
August 6, 2025Base award$71.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| United Oxygen Company, Inc. | Department Of Health And Human Services | March 23, 2026 | $46.9K |
| Glaxosmithkline, Llc | Department Of Health And Human Services | February 26, 2026 | $1.57M |
| Ohio State University, The | Department Of Health And Human Services | February 10, 2026 | $0 |
| Rotem Inc | Department Of Health And Human Services | January 28, 2026 | $19.8K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | January 22, 2026 | $0 |
| Roche Diagnostics Corporation | Department Of Health And Human Services | January 12, 2026 | $12.3K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N94025P00476?
Contract 75N94025P00476 is a federal contract awarded to Us Specialty Formulations Llc by Department Of Health And Human Services on August 6, 2025 for $72,000 of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N94025P00476?
Us Specialty Formulations Llc won contract 75N94025P00476 from Department Of Health And Human Services.
How much is contract 75N94025P00476 worth?
Contract 75N94025P00476 has obligated $72,000 to date.